Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2025-12-24 @ 10:08 PM
NCT ID:
NCT06572735
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 70 years
* Histologically or cytologically confirmed diagnosis of advanced ovarian cancer (FIGO stage III or IV)
* PARP inhibitors -naive patient who need to initiate maintenance treatment with PARP inhibitors for the first time (according the the marketing authorization)
* Patient with a life expectancy of more then 3 months
* Informed patient which does not oppose to participate to the study
Exclusion Criteria:
* Prior treatment with PARP inhibitors
* Patient incapable to take oral tablets/capsules
* Participation in a drug trial that does not authorize concurrent participation in another trials
* Person unable to attend scheduled examinations/appointments as part of routine care for geographical, social or psychological reasons
* Concomitant cancer or f cancer history (other than those included in the inclusion criteria) treated and considered cured for less than 2 years. However, patients with the following pathologies are eligible:
* Basal cell carcinoma or non-invasive cutaneous squamous cell carcinoma
* Stage 1B or less cervical carcinoma
* Non-invasive superficial bladder cancer
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
70 Years
Study:
NCT06572735
Study Brief:
Protocol Section:
NCT06572735